Search results for "STRAINS"

showing 10 items of 589 documents

Lateral differences in the GABAergic system of the rat striatum.

1985

Asymmetric differences have been found in the pre- and postsynaptic activity of the GABAergic system of the left and right striata of the rat. 3H-GABA binding shows a higher dissociation constant (KD) and a higher number of sites (Bmax) in the left striatum than in the right. Moreover, 3H-diazepam binding seems to be more extensively activated by GABA in the right striatum suggesting a more sensitive postsynaptic GABAergic activity than on the left side. However, when the presynaptic marker (GAD activity) was measured, the asymmetry was in the opposite direction. The results provide further neurochemical evidence of the functional asymmetry of the rat brain.

MaleRight striatumDermatologyStriatumSynaptic TransmissionRat striatumNeurochemicalPostsynaptic potentialBrain asymmetryAnimalsgamma-Aminobutyric AcidBinding SitesDiazepamChemistryGlutamate DecarboxylaseGeneral NeuroscienceRats Inbred StrainsGeneral MedicineCorpus StriatumRatsDissociation constantPsychiatry and Mental healthnervous system4-Aminobutyrate TransaminaseGABAergicNeurology (clinical)NeuroscienceItalian journal of neurological sciences
researchProduct

Cytostatic Activity of Aeroplysinin-1 against Lymphoma and Epithelioma Cells

1989

(±)-Aeroplysinin-1, an optically active 1.2-dihydroarene-1.2-diol. was isolated from the marine sponges Verongia aerophoba (+-isomer) and lanthella ardis (--isomer). For the experiments presented we used the +-isomer from Verongia aerophoba. Here we describe the hitherto unknown biological and pharmacological property of this compound to display pronounced anticancer activity against L5178y mouse lymphoma cells (ED50: 0.5 μm). Friend erythroleukemia cells (ED50: 0.7μm) , human mamma carcinoma cells (ED50: 0.3μm) and human colon carcinoma cells (ED50: 3.0 μm) in vitro. Furthermore, aeroplysinin caused a preferential inhibition of [3H]thymidine (dThd) incorporation rates in L5178y mouse lymph…

MaleSalmonella typhimuriumAcetonitrilesCell SurvivalCellAntineoplastic AgentsMice Inbred StrainsBiologyGeneral Biochemistry Genetics and Molecular BiologyCell LineMicechemistry.chemical_compoundIn vivoCyclohexenesTumor Cells CulturedmedicineCarcinomaAnimalsHumansLeukemia L5178ED50Leukemia ExperimentalMutagenicity TestsMelanomaCarcinomamedicine.diseaseVirologyMolecular biologyIn vitroLymphomamedicine.anatomical_structurechemistryDrug Screening Assays AntitumorThymidineZeitschrift für Naturforschung C
researchProduct

Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene

1987

3-Hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (3-OH-BP-7,8-diol) was isolated from arylsulfatase/beta-glucuronidase-treated bile of rats to which 3-hydroxybenzo[a]pyrene (3-OH-BP) has been administered. This triol was investigated for mutagenicity in Salmonella typhimurium (reversion to histidine prototrophy of strains TA 97, TA 98, TA 100 and TA 1537) and in V79 Chinese hamster cells (acquisition of resistance to 6-thioguanine). When no exogenous metabolizing system was added the triol was inactive, while 3-OH-BP showed weak mutagenic effects with all four bacterial strains. In the presence of NADPH-fortified postmitochondrial supernatant fraction (S9 mix) of liver homogenate fro…

MaleSalmonella typhimuriumCancer ResearchDiolHamsterMutagenIn Vitro TechniquesSecondary metabolitemedicine.disease_causeDihydroxydihydrobenzopyrenesStructure-Activity Relationshipchemistry.chemical_compoundBenzo(a)pyrenemedicineAnimalsBenzopyrenesBiotransformationCells CulturedDose-Response Relationship Drugbiologyfood and beveragesRats Inbred StrainsGeneral Medicinebiology.organism_classificationEnterobacteriaceaeRatsBenzo(a)pyrenechemistryBiochemistryMicrosomes LiverPyreneTriolMutagensmedicine.drugCarcinogenesis
researchProduct

Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A

1990

The phosphorylation of the 2 major phenobarbital-inducible cytochrome P450 isoenzymes IIB1 and IIB2 was increased in intact hepatocytes by the action of the membrane-permeating cAMP derivative N6,O2'-dibutyryl-cAMP. Under these conditions cyclophosphamide and ifosfamide (which are known to be activated by cytochrome P450 IIB1) were investigated for mutagenicity in Salmonella typhimurium TA1535 and TA100 and for cytotoxicity in TA1535. Cyclophosphamide and ifosfamide were transformed to mutagenic and cytotoxic metabolites by the hepatocytes. The activation of both drugs to mutagens was markedly reduced after pretreatment of the hepatocytes with the membrane-permeating cAMP derivative N6,O2'-…

MaleSalmonella typhimuriumCyclophosphamideHealth Toxicology and MutagenesisMetaboliteStimulationIn Vitro TechniquesPharmacologychemistry.chemical_compoundCytochrome P-450 Enzyme SystemTheophyllineGeneticsmedicineAnimalsTheophyllineIfosfamidePhosphorylationProtein kinase ACyclophosphamideMolecular BiologyIfosfamidebiologyCytochrome P450Rats Inbred StrainsRatsIsoenzymesBucladesineLiverchemistrybiology.proteinPhenobarbitalProtein KinasesMutagensmedicine.drugMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
researchProduct

Propyldazine is mutagenic inSalmonella typhimurium and Escherichia coli: Distinct specificity for strains TA1537 AND TA97

1985

The antihypertensive drug propyldazine (Atensil) was demonstrated to be muta- genic with auxotrophic mutants of Salmonella typhimurium and Escherichia coli. Addition of liver S9 mix (postmitochondrial supernatant fraction supplemented with an NADPH-generating system) had little, if any, effect on the mutagenicity. The mutagenicity showed an unusual pattern of strain specificity. Increased fre- quencies of reversion were observed with all strains whose auxotrophy was caused by frame-shift mutations: the number of revertant colonies per plate from S. typhimurium TA98, TA1538, TA97, and TA1537 was increased up to 5-, 9-, 43-, and 160-fold, respectively, above background. Among the strains that…

MaleSalmonella typhimuriumSalmonellaHealth Toxicology and MutagenesisAuxotrophyReversionMutagenBiologyToxicologymedicine.disease_causeAmes testMicrobiologySpecies SpecificityEscherichia coliGeneticsmedicineAnimalsEscherichia coliBiotransformationGenetics (clinical)DihydralazineStrain (chemistry)Mutagenicity Testsfood and beveragesRats Inbred StrainsHydralazineDihydralazineRatsPyridazinesOncologyMutationMicrosomes LiverMutagensmedicine.drugTeratogenesis, Carcinogenesis, and Mutagenesis
researchProduct

cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium.

1986

trans-Stilbene imine (trans-1,2-diphenylaziridine) is the nitrogen analog of trans-stilbene oxide, a potent inducer of several microsomal and cytosolic xenobiotic-metabolizing enzymes. Although the acute toxicity of cis- and trans-stilbene imines prevents their application at the usual dose for trans-stilbene oxide (400 mg/kg/day), it is apparent that the imines nevertheless potently induce several xenobiotic-metabolizing enzymes in rat liver. The IP administration of trans-stilbene imine resulted in statistically significant increases in the activities of aminopyrine N-demethylase, microsomal epoxide hydrolase, glutathione transferase (toward 1-chloro-2,4-dinitrobenzene, 1,2-dichloro-4-nit…

MaleSalmonella typhimuriumStereochemistryHealth Toxicology and MutagenesisImineAziridines10050 Institute of Pharmacology and Toxicology610 Medicine & healthMutagenToxicologymedicine.disease_causeAmes testchemistry.chemical_compound2307 Health Toxicology and MutagenesismedicineAnimalsToxicology and MutagenesisEnzyme inducerchemistry.chemical_classificationbiologyAzirinesMutagenicity Tests3005 ToxicologyRats Inbred StrainsStereoisomerismGeneral MedicineCis trans isomerizationRatsEnzymechemistryBiochemistryLiverHealthMicrosomal epoxide hydrolaseEnzyme InductionMicrosomebiology.protein570 Life sciences; biologyMutagensArchives of toxicology
researchProduct

Biphenyl and fluorinated derivatives: liver enzyme-mediated mutagenicity detected in Salmonella typhimurium and Chinese hamster V79 cells.

1992

Abstract Hepatocarcinogenic polychlorinated and polybrominated biphenyls usually show negative results in in vitro mutagenicity assays. Problems in their testing result from their low water solubility and their slow rate of metabolism. We therefore investigated better soluble model compounds, namely biphenyl and its 3 possible monofiuorinated derivatives. In the direct test, these compounds proved tobe nonmutagenic in Salmonella typhimurium TA98 and TA100 (reversion to histidine prototrophy) and in Chinese hamster V79 cells (acquisition of resistance to 6-thioguanine). However, when the exposure was carried out in the presence of NADPH-fortified postmitochondrial fraction of liver homogenat…

MaleSalmonella typhimuriumendocrine systemChinese hamsterAmes testCell LineToxicologychemistry.chemical_compoundStructure-Activity RelationshipCricetulusCricetinaeAnimalsBiotransformationBiphenylbiologyChemistryMutagenicity TestsBiphenyl CompoundsRats Inbred StrainsGeneral MedicineMetabolismbiology.organism_classificationEnterobacteriaceaeIn vitroRatsBiochemistryMicrosomal epoxide hydrolaseMicrosomes LiverPolybrominated BiphenylsMutation research
researchProduct

Mutagenicity spectra in Salmonella typhimurium strains of glutathione, L-cysteine and active oxygen species

1989

Glutathione and L-cysteine, in the presence of rat kidney post-mitochondrial supernatant (S9) fraction, and various forms of active oxygen were investigated for mutagenicity in seven his- strains of Salmonella typhimurium. Glutathione and L-cysteine showed qualitatively and quantitatively virtually identical mutagenic activities. The number of mutants induced in strain TA97 was 3-4 times higher than in TA100, the strain in which the mutagenicity was originally detected. Mutagenic effects were also observed in strains TA92, TA102 and TA104, but not in TA1535 and TA1537. Hydrogen peroxide, superoxide and glucose/glucose oxidase in the presence and absence of kidney S9 fraction showed pronounc…

MaleSalmonella typhimuriumendocrine systemHealth Toxicology and MutagenesisIn Vitro TechniquesKidneyToxicologyAmes testSuperoxide dismutasechemistry.chemical_compoundSuperoxidesGeneticsAnimalsCysteineBiotransformationGenetics (clinical)chemistry.chemical_classificationReactive oxygen speciesbiologyMutagenicity TestsSuperoxide DismutaseSuperoxidefungifood and beveragesKidney metabolismRats Inbred StrainsHydrogen PeroxideGlutathioneCatalaseGlutathioneRatsOxygenchemistryS9 fractionBiochemistryCatalasebiology.proteinMutagensMutagenesis
researchProduct

The effect of dietary imbalances on the activation of benzo[a]pyrene by the metabolizing enzymes from rat liver.

1987

Abstract Male Sprague-Dawley rats (70–80 g) were fed ad libitum a standard control diet (22% casein, 5% lard), or a high lipid diet (30% lard) or a low protein diet (6% casein) or a standard diet containing 50 ppm phenoclor DP6. After 6 weeks on these diets, the cytochrome P-450 microsomal content, the benzo[ a ]pyrene monooxygenase (BaP-MO) and the epoxide hydrolase (EH) were assayed. The formation of mutagenic B(a)P metabolites which covalently bind with DNA was compared. The activity of BaP-MO and of EH were increased by the high lipid diet (+27% and 106% respectively) and by the phenoclor DP6 treatment (+63% and 400% respectively), compared to the standard diet. In animals fed a low pro…

MaleSalmonella typhimuriummedicine.medical_treatmentchemistry.chemical_compoundLow-protein dietCaseinmedicineBenzo(a)pyreneAnimalsFood scienceEpoxide hydrolaseBenzopyrene HydroxylaseCarcinogenBiotransformationEpoxide HydrolasesCocarcinogenesisChemistryMutagenicity TestsRats Inbred StrainsGeneral MedicineMonooxygenaseDietary FatsPolychlorinated BiphenylsRatsBiochemistryBenzo(a)pyreneMicrosomeMicrosomes LiverPyreneAryl Hydrocarbon HydroxylasesDietary ProteinsDNA DamageMutation research
researchProduct

Early kinetics of integration of collagen-glycosaminoglycan regenerative scaffolds in a diabetic mouse model.

2013

Collagen-glycosaminoglycan scaffolds, originally designed to treat severe burns, are now commonly used in patients with complex wounds associated with diabetes mellitus. In this study, the authors investigated how the thickness of the scaffold would affect cellular integration with the diabetic host and whether this can be accelerated using subatmospheric pressure wound therapy devices.Collagen-glycosaminoglycan scaffolds, 500 to 2000-μm thick, were applied to dorsal wounds in genetically diabetic mice. In addition, 1000-μm collagen-glycosaminoglycan scaffolds with and without silicone were treated with a subatmospheric pressure device (-125 mmHg). On days 5 and 10, cellular and vascular in…

MaleScaffoldPathologymedicine.medical_specialtyMice Inbred StrainsGlycosaminoglycanDiabetes ComplicationsMiceTissue scaffoldsDiabetes mellitusMedicineAnimalsRegenerationSevere burnIn patientGlycosaminoglycansSkinintegumentary systemTissue Scaffoldsbusiness.industryDiabetic mouseAnatomymedicine.diseaseKineticsWounds and InjuriesSurgeryCollagenbusinessPlastic and reconstructive surgery
researchProduct